<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00526864</url>
  </required_header>
  <id_info>
    <org_study_id>MUTM2007-035</org_study_id>
    <nct_id>NCT00526864</nct_id>
  </id_info>
  <brief_title>Measuring Herpes Zoster and PHN Associated Burden of Illness and Health Care Utilization Costs in Thailand</brief_title>
  <official_title>Measuring Herpes Zoster and Post-Herpetic Neuralgia Associated Burden of Illness and Health Care Utilization and Costs in Thailand</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Total 7 institutions will be recruited i.e. Clinical Infectious Disease Research Unit&#xD;
      Department of Clinical Tropical Medicine, Faculty of Tropical Medicine Mahidol&#xD;
      University,Bamrasnaradura Infectious Disease Institute&#xD;
&#xD;
      ,Pramonkutklao Hospital,Rajavithi Hospital,NationalCancerInstitute,Institute of&#xD;
      Dermatology,Raj Pracha Samasai Institute&#xD;
&#xD;
      OBJECTIVES&#xD;
&#xD;
        -  Measure the burden of illness due to herpes zoster (Zoster) and post-herpetic neuralgia&#xD;
           (PHN) (severity and duration);&#xD;
&#xD;
        -  Assess the quality of life (QoL) and quality adjusted life years (QALY) lost due to&#xD;
           Zoster and PHN;&#xD;
&#xD;
        -  Describe health care resource utilization associated with Zoster and PHN;&#xD;
&#xD;
        -  Describe the direct and indirect costs per case of Zoster and PHN&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This will be a prospective cohort study of patients presenting with Zoster rash in 7&#xD;
      specialized institutions in Thailand.&#xD;
&#xD;
      Subjects will be entered in the cohort at the time of presentation with Zoster rash. After&#xD;
      the baseline assessment (day 0) that will be conducted at the investigator's office there&#xD;
      will be 4 assessments (prospective part of the study) that will be conducted at day 7, month&#xD;
      1, month 3 and month 6.&#xD;
&#xD;
      We expect that there will be approximately 150 patients included in the study cohort. Cohort&#xD;
      assembly will take place between April 2007 and October 2007.&#xD;
&#xD;
      The study will be conducted in 3 groups&#xD;
&#xD;
      Eligible patients for each group will include&#xD;
&#xD;
        -  Group A: Both male and female patients ≥ 50 years of age with Zoster rash.&#xD;
&#xD;
        -  Group B: Both HIV infected male and female patients ≥ 20 years of age with Zoster rash.&#xD;
&#xD;
        -  Group C: Both Oncology male and female patients ≥ 20 years of age who on chemotherapy&#xD;
           with Zoster rash.&#xD;
&#xD;
      Key exclusion criteria includes patient who refuses to sign informed consent.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2007</start_date>
  <completion_date type="Actual">July 2008</completion_date>
  <primary_completion_date type="Actual">July 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">180</enrollment>
  <condition>Herpes Zoster</condition>
  <arm_group>
    <arm_group_label>Elderly patients</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>HIV infected patients</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Immunosuppressed patients</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        total of 180 clinically diagnosed herpes zoster patients, either aged ‡ 50 years and&#xD;
        otherwise healthy, or ‡ 20 years with HIV infection, or ‡ 20 years and currently receiving&#xD;
        chemotherapy or immunosuppressive agents.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Physician confirmed diagnosis of Zoster rash&#xD;
&#xD;
          -  of onset of Zoster rash must be documented in the patient's chart.&#xD;
&#xD;
          -  Patient is capable of understanding the study and the content of the consent form and&#xD;
             has agreed to participate in the study by signing the informed consent.&#xD;
&#xD;
          -  Patient will be available for the study follow up period&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  no specific exclusion criteria&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Punnee Pitisuttithum, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Clinical Tropical Medicine, Faculty of Tropical Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University</name>
      <address>
        <city>Bangkok</city>
        <zip>10400</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <study_first_submitted>September 7, 2007</study_first_submitted>
  <study_first_submitted_qc>September 7, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 10, 2007</study_first_posted>
  <last_update_submitted>September 21, 2015</last_update_submitted>
  <last_update_submitted_qc>September 21, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 23, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mahidol University</investigator_affiliation>
    <investigator_full_name>Punnee Pitisuttithum</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Burden of Illness for Herpes zoster in Thailand.</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Herpes Zoster</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

